Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aditxt Inc.

ADTX
Current price
1.48 USD +0.09 USD (+6.47%)
Last closed 1.4 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 189 904 USD
Yield for 12 month +277.45 %
1Y
3Y
5Y
10Y
15Y
ADTX
21.11.2021 - 28.11.2021

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

61 USD

P/E ratio

Dividend Yield

Current Year

+645 176 USD

Last Year

+933 715 USD

Current Quarter

+81 297 USD

Last Quarter

+81 297 USD

Current Year

-654 243 USD

Last Year

+166 936 USD

Current Quarter

-337 492 USD

Last Quarter

-204 570 USD

Key Figures ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -31 348 112 USD
Operating Margin TTM -14477.47 %
PE Ratio
Return On Assets TTM -111.69 %
PEG Ratio
Return On Equity TTM -838.07 %
Wall Street Target Price 61 USD
Revenue TTM 506 441 USD
Book Value 5.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -63.5 %
Dividend Yield
Gross Profit TTM 166 936 USD
Earnings per share -64.83 USD
Diluted Eps TTM -64.83 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 18.08.2023
Dividend Date

Stock Valuation ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.3707
Enterprise Value Revenue 12.8974
Price Sales TTM 6.6877
Enterprise Value EBITDA -0.376
Price Book MRQ 0.3003

Financials ADTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADTX

For 52 weeks

1.35 USD 68.08 USD
50 Day MA 1.77 USD
Shares Short Prior Month 175 363
200 Day MA 3.6 USD
Short Ratio 5.07
Shares Short 177 152
Short Percent 8.95 %

Dynamics of changes in the value of assets

B

BYLG

0.28 USD Bylog Group Corp 0 (0%)
Detailed analytics
M

MPR

0.014 AUD Mpower Group Ltd 0 (0%)
Detailed analytics
F

F7E1

0.020 EUR FOKUS MINING CORP. 0 (0%)
Detailed analytics
S

SAHRF

0.0010 USD Sahara Energy Ltd 0 (0%)
Detailed analytics
H

HRU

1.15 EUR Horus AG +0.05 (+4.55%)
Detailed analytics